In most cancer types, MTAP deficiency is caused by homozygous co-deletion with cyclin dependent kinase inhibitor 2A (CDKN2A) gene at 9p21.3 which is homozygously deleted in up to 15 % of all human cancers [[2], [3], [4]]. Here, CDKN2A is linked to cancer.